Genetic Strategy to Decrease Complement Activation With Adenoviral Therapies

PLoS ONE - United States
doi 10.1371/journal.pone.0215226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Protease Inhibitors Decrease IgG Shedding From Staphylococcus Aureus, Increasing Complement Activation and Phagocytosis Efficiency

Journal of Medical Microbiology
MedicineMicrobiology
2011English

Complement Receptor 2–mediated Targeting of Complement Inhibitors to Sites of Complement Activation

Journal of Clinical Investigation
Medicine
2003English

The Role of Adenoviral Vectors in Genetic Prodrug Activation Therapy in Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

Complex Interactions With Several Arms of the Complement System Dictate Innate and Humoral Immunity to Adenoviral Vectors

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2008English

Complement Activation in Patients With Diabetic Nephropathy

Kidney International Reports
Nephrology
2018English

Duct Retrofit Strategy to Complement a Modulating Furnace.

2002English

Polyphosphates and Complement Activation

Frontiers in Medicine
Medicine
2019English

Activation of Complement (C3) in Patients With Leprosy

Leprosy Review
DermatologyMedicineInfectious Diseases
1971English

Complement Activation in Uveitis.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy